mRNA-1010 generated a strong immune response against all four WHO-recommended flu strains
The supply of cisplatin, carboplatin and methotrexate has nearly halved in the past year
The drugmaker expects to expand its research pipeline from six to 12 over next 18 months
The study will evaluate the ability of MSCopilot to identify early signs of disability worsening
The research grant will help to identify drug candidates for the treatment of the disease
Pfizer/BioNTech and Moderna’s updated vaccines will be available in the coming days
估计affe炎症性皮肤病ct 4.4% of adults in the EU
NSCLC is the most common type of lung cancer, representing up to 85% of diagnoses
Treatment options for the underdiagnosed and rapidly progressive condition are currently limited
Q&A: Claire GillisPME interviews VMLY&Rx's CEO
Q&A: Sarah GordonPME interviews Virgo Health's head of health
Q&A: Amar UrhekarPME interviews Ashfield Health's Global President
CureVac advances ‘promising’ seasonal flu mRNA vaccine to phase 2 developmentThe mid-stage study of the candidate is expected to begin in the fourth quarter of 2023
Moderna and Immatics announce oncology collaboration worth over $1.7bnThe agreement will focus on the development of bispecifics, cell therapies and cancer vaccines
AbbVie shares positive results from head-to-head study of Skyrizi in Crohn's diseaseThe late-stage study has been evaluating the drug against Johnson & Johnson’s Stelara
Takeda announces positive phase 2b results for TAK-279 in psoriatic arthritisApproximately 10 million people worldwide are affected by the inflammatory disease
IO Biotech announces new data supporting its therapeutic cancer vaccineThe vaccine showed promise when used in combination with Merck & Co’s Keytruda
NIHR awards £2.3m for AI study to improve radiotherapy for lung cancerThe AI tool is expected to help doctors plan each patient’s radiotherapy treatment
FDA approves Pfizer/BioNTech and Moderna’s updated COVID-19 vaccinesThe vaccines have both been adapted to target the currently circulating XBB.1.5 Omicron variant
Publicis Groupe UK promotes Victoria Wright to CEO of Publicis Health UKWright first joined the group in 2007 as general manager of Publicis Resolute
旗鱼Advertising promotes Sam Wright to creative directorWright originally joined the agency in 2019 as senior art director
redthread market access appoints Victoria Thomas as head of strategic market accessThomas joins the agency from health network company Havas M&C
The Considered promotes Tina Bertolini to head of operations and project managementBertolini originally joined the agency in 2021 as senior operations manager
Research Partnership announces two new senior leadership hiresSue Wild will be joining as president, US pharma and Tom Donnelly as a director in the US MedTech division
No results were found
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...
